Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$900M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$866M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$596M |
| 4 |
Clarivate
CLVT
|
+$284M |
| 5 |
Mastercard
MA
|
+$272M |
Top Sells
| 1 |
Wolfspeed
WOLF
|
+$1.11B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1,000M |
| 3 |
Apple
AAPL
|
+$925M |
| 4 |
Intel
INTC
|
+$462M |
| 5 |
Microsoft
MSFT
|
+$435M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBAI
2026
DELISTED
Lakeland Bancorp Inc
LBAI
| $6.86M | ﹤0.01% |
410,626
-13,949
| -3% | -$233K |
|
2027
Greif
GEF
$3.59B
| $6.85M | ﹤0.01% |
105,967
-3,879
| -4% | -$251K |
|
2028
Provident Financial Services
PFS
$2.59B
| $6.85M | ﹤0.01% |
307,909
-17,220
| -5% | -$383K |
|
2029
Strategic Education
STRA
$1.98B
| $6.84M | ﹤0.01% |
96,480
-5,437
| -5% | -$385K |
|
2030
Byline Bancorp
BY
$1.33B
| $6.83M | ﹤0.01% |
278,026
+29,774
| +12% | +$731K |
|
2031
Horace Mann Educators
HMN
$1.94B
| $6.83M | ﹤0.01% |
171,519
-198,500
| -54% | -$7.9M |
|
2032
First Busey Corp
BUSE
$2.19B
| $6.82M | ﹤0.01% |
276,897
-358,126
| -56% | -$8.82M |
|
2033
Karyopharm Therapeutics
KPTI
$55.9M
| $6.79M | ﹤0.01% |
74,601
-1,127
| -1% | -$103K |
|
2034
Inovio Pharmaceuticals
INO
$126M
| $6.79M | ﹤0.01% |
79,014
-101,178
| -56% | -$8.69M |
|
|
ADAM
2035
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $6.79M | ﹤0.01% |
388,215
-28,075
| -7% | -$491K |
|
2036
Virtu Financial
VIRT
$3.1B
| $6.78M | ﹤0.01% |
277,628
-172,582
| -38% | -$4.22M |
|
2037
Sutro Biopharma
STRO
$74.3M
| $6.77M | ﹤0.01% |
358,261
-47,934
| -12% | -$905K |
|
2038
Novo Nordisk
NVO
$244B
| $6.76M | ﹤0.01% |
140,908
-6
| -0% | -$288 |
|
|
DOYU
2039
DouYu International Holdings
DOYU
$231M
| $6.75M | ﹤0.01% |
205,189
+128,721
| +168% | +$4.24M |
|
2040
NewMarket
NEU
$7.87B
| $6.73M | ﹤0.01% |
19,860
-1,691
| -8% | -$573K |
|
2041
Enviri
NVRI
$983M
| $6.72M | ﹤0.01% |
409,419
-16,525
| -4% | -$271K |
|
2042
PJT Partners
PJT
$4.47B
| $6.71M | ﹤0.01% |
87,197
-17,216
| -16% | -$1.33M |
|
2043
Corcept Therapeutics
CORT
$7.68B
| $6.7M | ﹤0.01% |
340,159
-42,776
| -11% | -$842K |
|
2044
Evolus
EOLS
$465M
| $6.67M | ﹤0.01% |
810,979
+209,617
| +35% | +$1.72M |
|
|
DQ
2045
Daqo New Energy
DQ
$1.73B
| $6.61M | ﹤0.01% |
116,000
+31,700
| +38% | +$1.81M |
|
2046
Hydrofarm Holdings
HYFM
$15.3M
| $6.61M | ﹤0.01% |
14,502
+10,738
| +285% | +$4.9M |
|
2047
Lindsay Corp
LNN
$1.52B
| $6.61M | ﹤0.01% |
43,521
-8,333
| -16% | -$1.26M |
|
2048
Funko
FNKO
$182M
| $6.61M | ﹤0.01% |
346,373
+55,540
| +19% | +$1.06M |
|
2049
Ameresco
AMRC
$1.44B
| $6.55M | ﹤0.01% |
112,125
-25,957
| -19% | -$1.52M |
|
2050
CBIZ
CBZ
$3.01B
| $6.55M | ﹤0.01% |
202,411
-13,309
| -6% | -$430K |
|